I016* †
|
61
|
Female
|
Coagulase-negative staphylococci
|
Ceftazidime, bactrim, Sulperazole
|
Hematemesis
|
Survivor
|
I017* ‡§
|
50
|
Male
|
Coagulase-negative staphylococci
|
Ceftriaxone, ceftazidime, doxycycline, cloxacillin
|
Acute pancreatitis, nephrotic syndrome
|
Survivor
|
I018§¶¥
|
57
|
Male
|
Coagulase-negative staphylococci#
|
Vancomycin
|
T2D, CRF
|
Survivor
|
I019¤
|
58
|
Female
|
Staphylococcus aureus
|
Cloxacillin, ceftazidime
|
T2D, wound
|
Survivor
|
I020¶¥
|
66
|
Female
|
Coagulase-negative staphylococci#
|
Ceftazidime, ceftriaxone
|
T2D, ARF, tuberculosis
|
Non-survivor
|
I021¶
|
54
|
Female
|
Enterococcus spp.
|
Ceftazidime, cloxacilin
|
T2D, abscess
|
Non-survivor
|
I022§¶
|
37
|
Male
|
Coagulase-negative staphylococci#
|
Ceftriaxone, ceftazidime
|
T2D, ARF
|
Non-survivor
|
I023¶¤
|
70
|
Female
|
E. coli
|
Doxycycline, ceftazidime
|
T2D
|
Non-survivor
|
I024¶¥
|
56
|
Male
|
Coagulase-negative staphylococci
|
Meropenem, ceftazidime
|
T2D, RF
|
Survivor
|
I025*
|
50
|
Male
|
S. pneumoniae
|
Ceftriaxone, meropenem
|
T2D
|
Non-survivor
|
I026¶
|
57
|
Male
|
K. pneumoniae
|
Ceftriaxone, ceftazidime, bactrim
|
T2D
|
Survivor
|
Septicemic melioidosis (n = 13)
| | | | | | |
M016¶
|
39
|
Male
|
B. pseudomallei
|
Ceftazidime, bactrim, doxycycline
|
T2D
|
Survivor
|
M017¶
|
52
|
Female
|
B. pseudomallei
|
Norfloxacin, ceftazolin
|
T2D
|
Survivor
|
M020¶
|
61
|
Male
|
B. pseudomallei
|
Ceftriaxone, doxycycline, ceftazidime
|
-
|
Survivor
|
M021¶
|
56
|
Female
|
B. pseudomallei
|
Ceftriaxone, ceftazidime
|
T2D
|
Survivor
|
M022¶
|
18
|
Male
|
B. pseudomallei
|
Ceftazidime, cactrim
|
T2D
|
Survivor
|
M023¶
|
63
|
Male
|
B. pseudomallei
|
Bactrim, ceftazidime
|
T2D
|
Survivor
|
M024¶
|
44
|
Male
|
B. pseudomallei
|
Meropenem
|
T2D, RF
|
Survivor
|
M025¶
|
57
|
Male
|
B. pseudomallei
|
Ceftazidime
|
T2D
|
Survivor
|
M026¶
|
48
|
Male
|
B. pseudomallei
|
Ceftazidime, doxycycline, bactrim
|
T2D
|
Survivor
|
M027¶
|
44
|
Male
|
B. pseudomallei
|
Ceftriaxone, ceftazidime, meropenem
|
ARF
|
Survivor
|
M028¶
|
70
|
Male
|
B. pseudomallei
|
Ceftazidime, levofloxacin, bactrim
|
T2D
|
Survivor
|
M029¶
|
50
|
Male
|
B. pseudomallei
|
Ceftriaxone, ceftazidime
|
CRF
|
Non-survivor
|
M030¶
|
44
|
Male
|
B. pseudomallei
|
Ceftazidime, ceftriazone
|
T2D, tuberculosis
|
Survivor
|